PHIO:NASDAQ
Phio Pharmaceuticals Corp
$0.99
arrow_upward
+0.34%(+0.0034) 1D
$0.98
arrow_downward
-1.45% (-0.014)bedtimeAfter hours
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PHIO...
Open
$1.00
High
$1.02
Low
$0.97
Mkt. cap
11.50M
Avg. vol.
144.61K
Volume
0.00
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.39
Beta
0.84
Shares outstanding
11.62M
No. of employees
6
Open
$1.00
High
$1.02
Low
$0.97
Mkt. cap
11.50M
Avg. vol.
144.61K
Volume
0.00
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.39
Beta
0.84
Shares outstanding
11.62M
No. of employees
6
News stories
From web sources and news partners
Yahoo Finance
·
19 hours ago
Phio Pharmaceuticals to Present at The Global Markets Virtual Forum October 8, 2026
Profile
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
About Phio Pharmaceuticals Corp